Covered recipient · General Payments record
CANDACY GEORGE
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2022
$365.70
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $185.92 | 12 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $66.58 | 4 |
| Novo Nordisk AS | $55.07 | 4 |
| Lilly USA, LLC | $29.85 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $20.58 | 1 |
| Abbott Laboratories | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $13.84 | 09/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | 910352321 | CMS |
| ABBVIE INC. | $25.71 | 03/31/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891019267 | CMS |
| ABBVIE INC. | $12.70 | 04/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891019269 | CMS |
| ABBVIE INC. | $14.68 | 05/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891019271 | CMS |
| ABBVIE INC. | $13.49 | 09/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 891019273 | CMS |
| Lilly USA, LLC | $14.92 | 04/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917931023 | CMS |
| Lilly USA, LLC | $14.93 | 08/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 917924704 | CMS |
| Novartis Pharmaceuticals Corporation | $20.58 | 06/30/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893691907 | CMS |
| Novo Nordisk Inc | $13.67 | 01/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | 898774331 | CMS |
| Novo Nordisk Inc | $12.02 | 02/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899295025 | CMS |
| Novo Nordisk Inc | $13.33 | 03/10/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899388855 | CMS |
| Novo Nordisk Inc | $16.05 | 05/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | 899295033 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.